Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-08

Clinical Trial Update: Role of FGF21 in Breast Cancer

View source ↗

Summary

A clinical trial is evaluating the role of fibroblast growth factor 21 (FGF21) in breast cancer, with the study currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FGF21 (Fibroblast Growth Factor 21)

Snippet

Sponsor: Assiut University | Conditions: Breast Cancer | Status: NOT_YET_RECRUITING